ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Trelegy Ellipta Gains Expanded COPD Indication in Europe
americanpharmaceuticalreview
November 10, 2018“We are pleased that the European Commission has approved the expanded use of Trelegy Ellipta as this will enable even more COPD patients to benefit from this important medicine,” Dr. Hal Barron, Chief Scientific Officer and President, R&D, GSK, said. -
Trelegy Ellipta Gains Expanded COPD Indication in Europe
americanpharmaceuticalreview
November 10, 2018“We are pleased that the European Commission has approved the expanded use of Trelegy Ellipta as this will enable even more COPD patients to benefit from this important medicine,” Dr. Hal Barron, Chief Scientific Officer and President, R&D, GSK, said.
Pharma Sources Insight January 2025
